Great Lakes Advisors’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $430K | Sell |
11,822
-1,489
| -11% | -$54.1K | ﹤0.01% | 640 |
|
|
2025
Q1 | $482K | Sell |
13,311
-177,818
| -93% | -$6.44M | ﹤0.01% | 614 |
|
|
2024
Q4 | $8.04M | Sell |
191,129
-8,124
| -4% | -$342K | 0.07% | 232 |
|
|
2024
Q3 | $11.1M | Buy |
199,253
+166,732
| +513% | +$9.26M | 0.09% | 191 |
|
|
2024
Q2 | $1.34M | Buy |
32,521
+6,296
| +24% | +$259K | 0.01% | 530 |
|
|
2024
Q1 | $1.22M | Sell |
26,225
-1,548
| -6% | -$72.3K | 0.01% | 527 |
|
|
2023
Q4 | $1.33M | Sell |
27,773
-27,674
| -50% | -$1.32M | 0.01% | 501 |
|
|
2023
Q3 | $1.98M | Sell |
55,447
-14,216
| -20% | -$507K | 0.02% | 457 |
|
|
2023
Q2 | $3.21M | Sell |
69,663
-49,555
| -42% | -$2.29M | 0.03% | 404 |
|
|
2023
Q1 | $4.78M | Buy |
+119,218
| New | +$4.78M | 0.04% | 375 |
|
|
2021
Q2 | – | Sell |
-149,020
| Closed | -$17M | – | 744 |
|
|
2021
Q1 | $17M | Buy |
149,020
+8,734
| +6% | +$994K | 0.27% | 120 |
|
|
2020
Q4 | $19.4M | Buy |
+140,286
| New | +$19.4M | 0.35% | 87 |
|